Massive Bio alternatives and competitors
The closest alternatives to Massive Bio are Paradigm Health, Mendel, PhaseV and Triomics.
Oncology clinical trial matching and enrollment company based in Boca Raton, Florida.
6 alternatives to Massive Bio
What each product does, with its price as the vendor publishes it.
-
P
Clinical trial platform that embeds patient identification, eSource and data capture inside provider organizations so trials can run in routine care, paired with its own recruitment coordinators and eligibility specialists.
Price: No published price
-
M
Mendel, based in San Jose and backed by Oak HC/FT and DCM, sells Hypercube, a platform that reads unstructured patient records for chart review, cohort building and clinical trial prescreening.
Price: No published price
-
P
PhaseV provides clinical development software for pharmaceutical sponsors, biotechnology companies and contract research organizations, from offices in the Boston area and Tel Aviv, and says more than 40 biopharma companies and CROs use it.
Price: $50,000 per 12 months
-
T
Oncology AI that reads the whole patient chart. OncoLLM, a family of oncology-tuned models tuned further on each institution's records, reads every note, report, scan and fax and returns structured answers with a citation to the line in the chart behind each one.
Price: No published price
-
D
Dyania Health builds Synapsis AI, a medical language model that reads full electronic medical records and answers specific clinical questions, such as whether a patient meets each criterion of a trial.
Price: No published price
-
A
Alleviate Health provides conversational recruitment software for clinical research sites. Its agents contact potential participants, ask initial eligibility questions, and arrange an on-site visit or a call with a clinical research coordinator.
Price: No published price
Massive Bio alternatives, answered
What are the best alternatives to Massive Bio?
The closest alternatives to Massive Bio are Paradigm Health, Mendel, PhaseV, Triomics and Dyania Health. Mendel, based in San Jose and backed by Oak HC/FT and DCM, sells Hypercube, a platform that reads unstructured patient records for chart review, cohort building and clinical trial prescreening. PhaseV provides clinical development software for pharmaceutical sponsors, biotechnology companies and contract research organizations, from offices in the Boston area and Tel Aviv, and says more than 40 biopharma companies and CROs use it. Dyania Health builds Synapsis AI, a medical language model that reads full electronic medical records and answers specific clinical questions, such as whether a patient meets each criterion of a trial.
Who are Massive Bio's competitors?
Massive Bio's competitors in the Clinical Trials AI category include Paradigm Health, Mendel, PhaseV, Triomics, Dyania Health and Alleviate Health.